^
+ Follow MYCOPHENOLATE Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 277248
                    [Title] => Drug for kidney transplants hits RP market
                    [Summary] => Novartis Healthcare Phils. Inc. has announced that its newest product especially designed to prevent organ rejection for kidney transplant patients hit the Philippine market last April.


The product was launched at the recently concluded Philippine Society of Nephrology dinner-symposium held at the EDSA Shangri-La Hotel.
[DatePublished] => 2005-05-12 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
MYCOPHENOLATE
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 277248
                    [Title] => Drug for kidney transplants hits RP market
                    [Summary] => Novartis Healthcare Phils. Inc. has announced that its newest product especially designed to prevent organ rejection for kidney transplant patients hit the Philippine market last April.


The product was launched at the recently concluded Philippine Society of Nephrology dinner-symposium held at the EDSA Shangri-La Hotel.
[DatePublished] => 2005-05-12 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with